Orchid Pharma Ltd

Analyst / Investor Meet - Outcome

Audio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30, 2026

Company Update / Analyst / Investor Meet View filing →

Analyst / Investor Meet - Intimation

Intimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30, 2026.

Company Update / Analyst / Investor Meet View filing →

Outcome Of Board Meeting Held For Considering And Approving Revised Audited Financial Results For The Year Ended March 31, 2026 Pursuant To Scheme Of Merger.

Revised Audited financial results for the Financial year ended March 31, 2026 pursuant to Scheme of Merger

Company Update / General View filing →

Monitoring Agency Report

Monitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30, 2026.

Company Update / Monitoring Agency Report View filing →

Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026 On The Use Of Proceeds Of Funds Raised Through Qualified Institutional Placement

Statement of Deviation or variation for the quarter ended June 30, 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.

Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 14, 2026.

Orchid Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Limited reviewed financial ....

Board Meeting / Board Meeting View filing →

Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 01, 2026

Orchid Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Prior intimation of Board Meeting ....

Board Meeting / Board Meeting View filing →

524372 - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited ('Amalgamating Company') With Orchid Pharma Limited ('Amalgamated Company/Company') And Their Respective Shareholders And Creditors ('The Scheme') Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 '(SEBI Listing Regulations)', As Amended.

Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") and their respective Shareholders ....

Company Update / General View filing →

Board Meeting Outcome for Intimation Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ("SEBI Listing Regulations").

Outcome of the Board Meeting

Others / Outcome without intimation View filing →

Amendments to Memorandum & Articles of Association

Outcome of Board Meeting: Amendment in the Capital Clause of Memorandum of Association of Company pursuant to the effectiveness of Scheme of Amalgamation of Dhanuka Laboratories Limited ....

Company Update / Amendments to Memorandum & Articles of Association View filing →

Corporate Action For Fixation Of Record Date

Fixation of Record Date pursuant to scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited for alloting shares to Shareholders of Dhanuka Laboratories Limited

Corp. Action / Record Date View filing →

Closure of Trading Window

Intimation of trading window closure for the Quarter-I of Financial Year 2026-27, ending on June 30, 2026

Insider Trading / SAST / Closure of Trading Window View filing →

Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited And Orchid Pharma Limited

Update for receipt of copy of order related to scheme of Amalgamation of Dhanuka Laboratories limited and Orchid Pharma limited

Company Update / General View filing →

Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited ('Amalgamating Company') With Orchid Pharma Limited ('Amalgamated Company') And Their Respective Shareholders And Creditors ('The Scheme') Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

In continuation to our earlier intimation dated March 18, 2026, with respect to merger petition, we would like to inform that Hon'ble National Company Law Tribunal ("NCLT") on June 05, ....

Company Update / General View filing →